Related Experiment Video
Updated: May 6, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
[Sphingosine kinase 1 and tumor]
Cai-Xia Zhang1, Hong-Wei He, Rong-Guang Shao
1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
The sphingolipid-rheostat balances cell fate via ceramide/sphingosine and sphingosine 1-phosphate (S1P). Sphingosine kinase 1 (SphK1) regulates this balance, impacting cell processes and cancer development, making it a potential therapeutic target.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Sphingolipids critically regulate cell functions, with ceramide (Cer) and sphingosine (Sph) inducing apoptosis and inhibiting proliferation.
- Sphingosine 1-phosphate (S1P) conversely promotes cell survival and proliferation.
- The balance between Cer/Sph and S1P, termed the 'sphingolipid-rheostat,' dictates cell fate.
Purpose of the Study:
- To review the role of sphingosine kinase 1 (SphK1) in fundamental biological processes.
- To explore the involvement of SphK1 in tumorigenesis.
- To evaluate SphK1 as a potential therapeutic target for cancer treatment.
Main Methods:
- Literature review focusing on sphingolipid metabolism.
- Analysis of studies investigating sphingosine kinase 1 function.
- Examination of research on SphK1 in cancer biology.
Main Results:
- Sphingosine kinases, particularly SphK1, are key regulators of the sphingolipid-rheostat.
- SphK1 plays a significant role in diverse cellular processes.
- Dysregulation of SphK1 is implicated in the development and progression of various cancers.
Conclusions:
- SphK1 is a critical modulator of cell fate through its regulation of the sphingolipid balance.
- Targeting SphK1 offers a promising strategy for novel cancer therapies.
- Further research into SphK1's mechanisms could unlock new therapeutic avenues.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
PI3K/mTOR/AKT Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The JAK-STAT Signaling Pathway

